Perrigo sets recovery plan at Canaccord growth conference

Perrigo Co. (NYSE: PRGO) outlined a strategic reset aimed at driving recovery during a presentation at the Canaccord Genuity Growth Conference on Tuesday.

The Dublin-based pharmaceutical company, which specializes in over-the-counter health and wellness products, described the initiative as a multi-faceted approach to address operational inefficiencies and restore profitability. Key focus areas include portfolio optimization, cost restructuring, and accelerating growth in core markets.

Perrigo’s management team emphasized the importance of disciplined capital allocation and operational discipline to navigate current market headwinds, including supply chain pressures and regulatory scrutiny. The company did not disclose specific financial targets but indicated that the reset would position it for sustainable long-term growth.

Shares of Perrigo rose modestly following the presentation, reflecting investor optimism about the outlined recovery strategy. The company’s stock has underperformed broader pharmaceutical indices over the past year, pressured by weaker-than-expected earnings and competitive pressures in its consumer health segment.

Analysts at Canaccord Genuity noted that Perrigo’s reset plan aligns with industry trends toward operational efficiency and margin recovery. The firm’s ability to execute on these initiatives will be closely watched in upcoming quarters, particularly as it seeks to regain market share in key product categories.

Perrigo did not provide updated guidance during the conference but reiterated its commitment to delivering shareholder value through improved operational performance.